-
-
-
-
-
-
-
LivaNova plc (LIVN) Tops Q1 EPS by 8c, Beats on Revenue; Offers FY26 EPS Guidance
-
-
-
-
-
-
-
This MedTech stock is 'favorite SMID value name' on Piper's list
-
-
-
-
-
-
-
LivaNova (LIVN) Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
-
-
-
-
-
-
-
Livanova (LIVN) PT Raised to $168 at Goldman Sachs
-
-
-
-
-
-
-
Wolfe Research Upgrades Livanova (LIVN) to Outperform
-
-
-
-
-
-
-
Livanova (LIVN) PT Lowered to $60 at Mizuho
-
-
-
-
-
-
-
LivaNova plc (LIVN) Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
-
458,123 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

